Chemical Structure : Nezulcitinib
Catalog No.: PC-38381Not For Human Use, Lab Use Only.
Nezulcitinib (TD-0903) is a inhaled lung-selective pan-JAK inhibitor, targets all JAK isoforms (JAK1, JAK2, JAK3, TYK2), Nezulcitinib is under development for treatment of acute lung injury associated with COVID-19.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Nezulcitinib (TD-0903) is a inhaled lung-selective pan-JAK inhibitor, targets all JAK isoforms (JAK1, JAK2, JAK3, TYK2), Nezulcitinib is under development for treatment of acute lung injury associated with COVID-19.
M.Wt | 527.673 | |
Formula | C30H37N7O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Singh D, et al. Eur Respir J. 2021 Oct 14;58(4):2100673.
2. Spinelli, F. R., Conti, F. & Gadina, M. HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19. Sci. Immunol. 5, eabc5367 (2020).
3. Pfeifer ND, et al. Clin Transl Sci. 2021 Nov;14(6):2556-2565.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright